Abbvie Net Revenue

Net Revenue of Abbvie 2008-2021

Amounts are in $millions.

YearNet Revenue ($mn)
2021$56,197
2020$45,804
2019$33,266
 2018$32,753 
2017 $28,216
2016$25,638 
2015 $22,859
2014$19,960 
2013$18,790 
2012 $18,380
2011 $17,444
2010$15,638 
2009 $14,214
2008$14,179 

2021: In 2021, the net revenues of AbbVie grew to $56.2 billion compared to $45.8 billion in 2020.

Net Revenue of AbbVie in 2018 grew to $32.8 billion compared to $28.22 billion in 2017.

AbbVie is a global, research-based biopharmaceutical company. It develops and markets advanced therapies for some of the world’s most complex and serious diseases. Its products are made to treat conditions like chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, like Parkinson’s disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; as well as other serious health conditions.